Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Plain-language summaries of 10,888 rare conditions, drawn from MONDO, GeneReviews, ClinVar, FDA, NIH, ClinicalTrials.gov, PubMed, and 5 other public sources. Free, sourced, never gated.
Kisho provides public health information only — not medical advice. Always consult your healthcare provider.
12
authoritative sources — clinical, regulatory, scientific
10,888
rare conditions, continuously monitored
Daily
updates from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet…
Showing 3,601-3,620 of 10,888 diseases
MONDO:0013811
Combined oxidative phosphorylation defect type 9 is a mitochondrial disorder that impairs energy production due to a defect in mitochondrial protein s...
MONDO:0000732
Combined oxidative phosphorylation deficiency is a mitochondrial disorder characterized by dysfunction in multiple respiratory chain complexes. As a c...
MONDO:0014269
Combined oxidative phosphorylation deficiency 19 is a severe metabolic condition resulting from pathogenic variants in the LYRM4 gene and affects mito...
MONDO:0020727
Combined oxidative phosphorylation deficiency 22 is a severe metabolic disorder that primarily affects multiple organ systems, particularly the nervou...
MONDO:0014775
Combined oxidative phosphorylation deficiency 28 is a condition that disrupts the body’s ability to produce energy efficiently due to impaired mitocho...
MONDO:0014781
Combined oxidative phosphorylation deficiency 29 is a very rare genetic condition caused by mutations in the TXN2 gene that disrupt normal cellular en...
MONDO:0054654
Combined oxidative phosphorylation deficiency 32 is a multi-system condition that affects energy production in the body. It is caused by pathogenic va...
MONDO:0054677
Combined oxidative phosphorylation deficiency 33 is a multisystem disorder that affects mitochondrial energy production, particularly impacting the he...
MONDO:0054741
Combined oxidative phosphorylation deficiency 34 is a multisystem condition that primarily affects energy metabolism, with key features involving mult...
MONDO:0054742
Combined oxidative phosphorylation deficiency 35 is a condition affecting energy production in multiple organ systems, with significant impact on neur...
MONDO:0054781
Combined oxidative phosphorylation deficiency 36, also known as COXPD36, is a multisystem metabolic disorder affecting energy production in cells. The...
MONDO:0032679
Combined oxidative phosphorylation deficiency 37 is a multisystem disorder that primarily affects energy production in the body, with significant invo...
MONDO:0032712
Combined oxidative phosphorylation deficiency 38 is a multisystem condition that affects energy production in the body, with a significant impact on t...
MONDO:0032726
Combined oxidative phosphorylation deficiency 39 is a multisystem condition that primarily affects mitochondrial energy production. It is caused by pa...
MONDO:0030006
Combined oxidative phosphorylation deficiency 40 is a multi-system condition that affects several organ systems, including the hematologic, cardiac, m...
MONDO:0030007
Combined oxidative phosphorylation deficiency 41 is a multi-system condition that affects energy production in several organs, leading to a range of c...
MONDO:0030008
Combined oxidative phosphorylation deficiency 42 is a multisystem condition that disrupts the body’s energy production processes. It is caused by path...
MONDO:0030017
Combined oxidative phosphorylation deficiency 43 is a multisystem disorder that primarily affects energy production and growth in early infancy. It is...
MONDO:0030020
Combined oxidative phosphorylation deficiency 44 is an inherited disorder that affects the body’s ability to produce energy at the cellular level, lea...
MONDO:0033533
Combined oxidative phosphorylation deficiency 45 is a multisystem condition that disrupts the body’s ability to generate energy effectively. It is cau...
Built from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet, and 7 more public sources. Updated daily.